chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt experienced a prickly heat burning rash on her face, which spread to her arms and chest the next day and cleared after one day. (01/12/2000) Pt experienced tightness in chest, chills, backache and aches in all joints. (01/17/2000) Symptoms resolved without treatment. (01/13/2000) Pt experienced sore throat, headache, burning and itching in corners of eyes without redness or swelling.  By the afternoon she had water blisters in back of mouth and on uvula and sore throat. Taste was distorted, she coughed up clear phlegm and had right abdominal soreness and watery diarrhea. Pt had insomnia that night. (01/14/2000) Pt had nausea. All symptoms resolved by 01/17/2000. As of 01/25/2000, pt felt like catching a cold or something now and my ears hurt a little bit.
Fainted after the shot, did not fall or hit on fall. Given some drink and got recovered after 10-15 minutes.
syncope; nausea; vomiting; This is a spontaneous report from a contactable consumer (patient). A 91-year-old male patient received the first dose of bnt162b2 (Lot/batch number and Expiration date were not provided), via an unspecified route of administration in right arm on 18Feb2021 13:00 at single dose for covid-19 immunization. Medical history included dementia, diabetes, chronic kidney failure, known allergies: pencillin. Concomitant medication included insulin, metoprolol, memantine, omeprazole (PROTONIX), apixaban (ELIQUIS). On 20Feb2021 21:00, the patient experienced syncope followed by nausea and vomiting lasting about 4 hrs. No treatment received. Events resulted in Doctor or other healthcare professional office/clinic visit. The outcome of the events was recovered on 21Feb2021 01:00.  Information on the lot/batch number has been requested.
Initial report was received on 15 April 2011 from another manufacturer national service center (service request number 1-4077276394), who received the report from a health care professional.  A male patient with an unreported past medical history had received a "tetanus vaccine" (manufacturer, lot number, route and site of administration were not reported) on an unspecified date years ago and an unspecified amount of time later experienced an anaphylactic reaction.  No further information was provided and at the time of the report the condition of the patient had not been reported.  Documents held by sender: none.
Student reported shaking and feeling like heart was racing. Blacked out while in car with parents. EMS was called to store 6/6/2021. Student had shaking all day on Sunday and diarrhea. Student continues to complain of stomachache's , lightheaded and chest pain to center of chest that comes and goes and is a stabbing pain
This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (if he moves his arms afterwards, he has overall less pain) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016MZ0A) for COVID-19 vaccination. No Medical History information was reported. On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (if he moves his arms afterwards, he has overall less pain). At the time of the report, PAIN IN EXTREMITY (if he moves his arms afterwards, he has overall less pain) outcome was unknown. mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged. No concomitant medications reported. No treatment reported. This case was linked to MOD-2022-461467 (Patient Link).
The following day of 1st vaccine, woke up severely dizzy; Vertigo; Severe headache; Nauseous; Feeling off; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the left arm on 01Mar2021 at 09:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure (HBP), breast cancer, stent in carotid artery, coil in aneurysm. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included losartan (MANUFACTURER UNKNOWN), clopidogrel (MANUFACTURER UNKNOWN), rabeprazole (MANUFACTURER UNKNOWN) and atorvastatin (MANUFACTURER UNKNOWN); all were from an unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received amoxicillin (MANUFACTURER UNKNOWN) and experienced drug allergy. On 02Mar2021 at 08:00, the following day of 1st vaccine, the patient experienced woke up severely dizzy, vertigo, severe headache nauseous was in bed for 3 days with these symptoms and as of today still feel dizzy, headache and feeling off she did not know if she should get 2nd shot. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events the following day of 1st vaccine woke up severely dizzy, vertigo, headache, nauseous and feeling off was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Information has been received from a physician concerning an 18 year old female who on 23 Oct 2006 was vaccinated with 0.5mL of Gardisil (yeast). There were no concomitant medications reported. On 23 Oct 2006, the patient developed a high fever of 102 degrees after receiving shot of Gardisil. The temperature continued for three days and was now noted at 100 degrees. The patient also developed achy legs. The patient sought unspecified medical attention. At the time of this report, the patient had not recovered from the events. Additional information has been requested.  This is in follow-up to report (s) previously submitted on 11/14/2006.  Initial and follow up information has been received from a physician concerning an 18 year old white female student who on 23-OCT-2006 was vaccinated intramuscularly in the arm with the first 0.5 mL dose of GARDASIL.  There were no concomitant medications reported.  On 23-OCT-2006, the patient developed a high fever of 102 degrees after receiving shot of GARDASIL.  The temperature continued for three days and on 26-OCT-2006 was noted at 100 degrees.  The patient also developed achy legs.  On 30-OCT-2006, that next week, the patient was diagnosed with mononucleosis.  At the time of this report, the outcome of the events were unknown.  Additional information has been requested.
Swelling in the arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swelling in the arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-May-2021, the patient experienced PERIPHERAL SWELLING (Swelling in the arm). At the time of the report, PERIPHERAL SWELLING (Swelling in the arm) outcome was unknown.      Action taken with mRNA-1273 in response to the events was not applicable  No concomitant medications provided No treatment medications provided
Day after vaccine administered patient developed redness at site of DTaP injection.  Patient seen 2 days after injection and a 6 x 9cm area of erythema/induration and warmth was noted at site.  Patient given Atorox laflex, to cover for allergy and infection.
On 11/05/2022 I had irritation in my lungs, runny nose and tiredness. I wrote email to my doctor on the same day. She replied to me back on 11/07/2022. She was going to prescribed me PAXLOVID because of the medication I take, she prescribed me LAGEVERIO (molnupiravir) 200 milligrams. I took 8 capsules per day instead.
Localized swelling and erythema approximately 10X12 cm over left deltoid; Localized swelling and erythema approximately 10X12 cm over left deltoid; Initial information received on 29-Mar-2019 regarding an unsolicited valid non-serious case received from a non-healthcare professional/ consumer via Health Authorities under reference .  This case involves a 4 years old female patient who experienced localized swelling and erythema approximately 10x12 cm over left deltoid, while she received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 24-Oct-2018, the patient received a single dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot uj041aa via intramuscular route in the left deltoid (LA).  On 24-Oct-2018, the patient developed a non-serious localized swelling and erythema approximately 10x12 cm over left deltoid (injection site erythema) and (injection site swelling) 1 day following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  (Other relevant tests included No lab data reported.)  Final diagnosis was localized swelling and erythema approximately 10x12 cm over left deltoid.   It was not reported if the patient received a corrective treatment.  The patient outcome is reported as Unknown for localized swelling and erythema approximately 10x12 cm over left deltoid.
Started to develop weakness, muscle aches, and a bit confused, the next morning I had a fever all day of about 101. Took Tylenol and slept on and off as well as drank a lot of water. Could not eat solid foods, but only lasted a day. This morning I still have some left over soreness but otherwise ok and little exhausted
Injection given in left deltoid, patient bled a little so cotton ball was applied, when cotton removed one inch area was swollen. A few minutes later the swollen area was close to two inches and ice was applied. After ice swelling went down after five minutes to one inch area. Ice continued to be applied.
pt rcvd vax; 48 hrs after vax pt devel rash on face & chest; pinpoint red blisters & pustules; pt had upper respiratory infect symptoms;
persistent & inconsolable crying lasting 3hr;started 10-15mo p/vax;
almost killed my youngest daughter; This case was reported by a consumer via interactive digital media and described the occurrence of near death experience in a female patient who received DTPa (Reduced antigen) (dTpa vaccine) for prophylaxis.   On an unknown date, the patient received dTpa vaccine. On an unknown date, unknown after receiving dTpa vaccine, the patient experienced near death experience (serious criteria GSK medically significant and life threatening). On an unknown date, the outcome of the near death experience was unknown.   The reporter considered the near death experience to be related to dTpa vaccine.  Additional details were provided as follows: This case was reported by the patient's parent. The age at vaccination was not reported. The reporter stated that dtap almost killed the patient and also stated it was hard pass for them.
Pt states he had his 2nd Covid vaccination at his County Health Department on 6/10/21 and later the same day he began having significant difficulty breathing. He did not seek treatment and it resolved 24 hours later. he also claims he had significant pain in arm that vaccination was given in. Both symptoms have resolved.
Patient felt as though she had aches and pains the first day which is normal.  The next day, 11-5-19 she stated her mouth was itchy and there were sores.    She came into the pharmacy on 11-13-19 to report the incident, and she is feeling very well today.  She was concerned about receiving the second dose.  I told her I agreed with her about the second dose.  She should consult her primary doctor about the next administration of shingrix if at all.
Pain migrated to the shoulder and now I feel a lot of pain in that area; Can't even get it lift my arm more than a certain point and therefore have low mobility in my shoulder; Arm started to hurt in the injection area; This spontaneous case was received on 14-Nov-2022 from other non-healthcare professional(consumer) (reference number SEQW22-0579) with additional information received on 16-Nov-2022 (being processed together) and concerned a 64-years-old, female patient.  The patient's concurrent condition included anxiety.The patient's concomitant medications included Cymbalta (duloxetine hydrochloride), mirtazapine and clonazepam, all used for unrepotrted indication.   On 29-Sep-2022, the patient was vaccinated with Afluria Quadrivalent (influenza vaccine inact split 4v; dose: 0,5 ml, route of administration: intramuscular and anatomical location: not reported), for influenza prophylaxis. The batch number was AS3614B and expiry date: 30-Apr-2023.   On the same date, after receiving Afluria Quadrivalent, the patient's arm started to hurt in the injection area. The pain migrated to the shoulder and the patient felt a lot of pain in that area. The patient didn't lift her arm more than a certain point and therefore have low mobility in shoulder.   On unspecified date, the patient started treatment with prednisolone and Celebrex (celecoxib).  On unspecified date, the patient stopped treatment with prednisolone. The patient was planning to make X-ray and if nothing appears to do a Magnetic resonance imaging (MRI).  At the time of initial report on 14-Nov-2022, the patient had not recovered from all events. The patient still had the pain in the shoulder and arm and was not able to lift her arm.  The reporter did not provide causality assessment.  The reporter assessed the case as non-serious.  Company comment: The events of shoulder pain, injected limb mobility decreased and vaccination site pain are assessed as possibly related to Afluria Quadrivalent due to plausible temporal relationship.; Sender's Comments: The events of shoulder pain, injected limb mobility decreased and vaccination site pain are assessed as possibly related to Afluria Quadrivalent due to plausible temporal relationship.
This spontaneous report was received from a nurse referring to a patient of unknown age and gender. Information of concurrent condition, medical history and concomitant therapy were not provided. On 18-OCT-2018, the patient was administered with a dose of expired M-M-R II (expiration date 26-SEP-2018, lot # M039914, therapy type recombinant Human albumin (rHA)) (strength, dose, frequency and route were not reported) and sterile diluent for prophylaxis. No adverse event reported.
Approximately 1 pm. Day after vaccine given red area approximately 1 1/2 inch diameter. Hot to touch. Day 2 - after being covered, area slightly larger and raised. Approximately 3pm.
Swollen, redness, sore (leg) Tylenol given at 8:00 am
I had a sore throat and a stuffy nose. I tested positive on the next day. I took PAXLOVID on day 2. It took about 3 days to resolve. I started having symptoms again after 5 days. I was diagnosed with a rebound case of COVID-19. I did not take any additional medication and it took about 10 days for the symptoms to resolve and I have since completely recovered.
This spontaneous report as received from a other health professional refers to a patient of unknown age. On 25-JUL-2017 the patient was vaccinated with ZOSTAVAX lot # M024700, expiry date 18-JUL-2017 0.65 ml, subcutaneous for prophylaxis. On 25-JUL-2017, 1 day after onset of therapy the patient experienced expired product administered. On an unknown date the patient experienced no adverse event. The outcome of expired product administered and no adverse event is unknown. The reporter considered expired product administered and no adverse event to be not related to ZOSTAVAX.
Next day in afternoon  (4/8/2021) while  sitting comfortably and relaxed at home, heart started racing. rate 183-160. Paramedics called, gave me 10 Mgs of Cardizem IV push then transported to ER.  Rate in NSR by arrival in ER, kept overnight for observation. Toprol. XL started by mouth by cardiologist then discharged home  in evening Of 4/9/2021.
problems with sleeping; weird noises that she was hearing; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from medical information team. The reporter is the patient.  A 72 year-old female patient received bnt162b2 (BNT162B2), administration date 26Mar2021 (Lot number: ER8730) at the age of 71 years as dose 2, single and administration date 05Mar2021 (Lot number: EN6206) as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. The patient took concomitant medications. The following information was reported: SLEEP DISORDER (non-serious) with onset Oct2021, outcome "unknown", described as "problems with sleeping"; TINNITUS (non-serious) with onset Oct2021, outcome "unknown", described as "weird noises that she was hearing".  Additional information: The reporter had been taking daily medications that she had never had a reaction to them before or after she got the vaccine. The reporter declined to provide this information at the time of reporting. The patient clarified that she received the vaccine last Mar2021. These events started happening after both of the dose that the reporter had. The reporter's symptoms began about 2 months ago, about Oct2021. The reporter thought she had a reaction to the graphine oxide nanoparticles, which were in the vaccine. The patient stated that the sleeping problems came from the graphene oxide nanoparticles found in the vaccine that was causing a weird electroactivity with the internet. The reporter started noticing some odd things going on. The reporter had internet in her home and she was wondering if this had anything to do with that. The caller also had her meter changed from a smart meter to a normal analog meter and she was still having weird noises that she was hearing and she thought it was from the graphine oxide nanoparticles in the vaccine. The reporter had never experienced any of this. This was causing problems with the reporter's sleeping. The patient wanted to know if graphene oxide was part of the ingredients of the vaccine and was actually causing her sleep problems. Graphene oxide was not used during the manufacturing of the vaccine and the vaccine did not contain. The patient took bnt162b2 because the reporter's doctor recommended it and when she usually got a virus, it got right to lungs. The caller had the influenza vaccine in Sep2021, the one for people over 65 years old, and she never had a reaction to them.   No follow-up attempts are needed. No further information is expected.
The potential AE is a fever of 101.2 degrees Fahrenheit.; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (The potential AE is a fever of 101.2 degrees Fahrenheit.) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (The potential AE is a fever of 101.2 degrees Fahrenheit.). At the time of the report, PYREXIA (The potential AE is a fever of 101.2 degrees Fahrenheit.) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.2 (High) 101.2 degrees fahrenheit.         No concomitant medication was reported.  No treatment medication was reported.
Around 5 pm on 2/11 (day of vaccination) I began to notice a very sore arm and dry mouth/dehydration. Drank water and continued as normal. Around 2 am of 2/12 I woke up with chills and had been sleeping very restlessly.  I had body aches in my arm, legs and back. Around 3am my temperature was 100.2. I also felt very faint when standing and thought I may pass out.  3 times when standing, I had to quickly sit down to avoid it. I do suffer from vasovagal syncope so this may be unrelated to vaccination. I took Tylenol and drank more water. Temp rose to about 100.6 before beginning to drop at around 4 am. I continued to take Tylenol every 4 hours and it helped keep temp below 100 but towards the end of the 4 hours, it would start to rise again. I ate normally and drank extra water due to feeling dehydrated still. Around 1 PM 2/12 I started to feel nauseous and had an upset stomach. I was still have a general body aches and elevated temperature around 99.5. My normal temp is usually about 98.0. Nausea led to diarrhea 1 time. Symptoms continued until approximately 8 pm when very quickly the body aches, nausea, fever and soreness in injection arm all went away. None of these symptoms have returned and it is now 2/13 at 8 pm.   I did test positive for Covid-19 on December 28, 2020 but have been fully recovered with no symptoms since 1/8/2021.
Administered 5/23. Patient reported symptoms 48-72 hours later. Had PNEUMOVAX and ZOSTAVAX vaccine sometime in different arms. In ZOSTAVAX injection site patient reports "redness, heat, pain 7/10". An approximate 4 inch x 1 inch rash is visible.
Dr.; the following day 12/16/2020, I woke up feeling more fatigue then usual with a migraine. Severe with nausea and light sensitivity. AE occurred about 4 hours. Resolved with Advil and Zofran.  Missed work 12/16/2020.  12/17/2020 feel back to normal
Tested positive to COVID after being vaccinate in March and April/runny nose; Tested positive to COVID after being vaccinate in March and April/runny nose; This is a spontaneous report from a contactable consumer (patient). A 17-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in the left arm on 26Mar2021 (at the age of 17-years-old) (Batch/Lot Number: EP6955) as dose 1, single then intramuscular, administered in the left arm on 16Apr2021 (Batch/Lot Number: EP6955) as dose 2, single for COVID-19 immunization. Medical history included allergies: penicillin. Concomitant medications were not reported. On 15Aug2021, the patient experienced runny nose. The patient had a nasal swab on 16Aug2021 that resulted positive. The patient tested positive to COVID after being vaccinate in March and April. The events were considered non-serious by the consumer. The patient was recovering from the events and had no treatment.  No follow-up attempts are possible. No further information is expected.
Got chills. Shaking. Fever. Felt weak. Sick all night. Got fever, need ice pack to cook down. Headaches. Almost called paramedics. I still have a headache and feel lightheaded today.
felt sick after booster shot; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  An adolescent male patient received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Batch/Lot No: Unknown. Not available/provided to reporter at the time of report completion), for COVID-19 immunization; Bnt162b2 (DOSE 2, SINGLE, Batch/Lot No: Unknown. Not available/provided to reporter at the time of report completion), for Covid-19 immunization.  The following information was reported: ILLNESS (non-serious) with onset Apr2022, outcome "unknown", described as "felt sick after booster shot". It was unknown if therapeutic measures were taken as a result of illness.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.